Overview
- Senator Joël Guerriau is accused of drugging Deputy Sandrine Josso with MDMA at his Paris residence in November 2023 to facilitate a sexual assault.
- Toxicology reports confirmed Josso had 388 ng/ml of ecstasy in her blood, a level far exceeding recreational doses, with no prior drug use detected for seven months.
- Digital evidence revealed Guerriau conducted searches related to drugs and sexual assault, pointing to premeditation according to investigators.
- The Paris prosecutor’s office formally requested a trial on April 7, 2025, with Guerriau remaining under judicial control and suspended from parliamentary activities.
- The case has intensified scrutiny of abuse of power in French politics and raised calls for accountability in addressing gender-based violence.